Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
äŒæ¥ã³ãŒãSTVN
äŒç€ŸåStevanato Group SpA
äžå Žæ¥Jul 16, 2021
æé«çµå¶è²¬ä»»è
ãCEOãStevanato (Franco)
åŸæ¥å¡æ°5521
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jul 16
æ¬ç€Ÿæåšå°Piombino Dese (Pd) Via Molinella, 17
éœåžPIOMBINO DESE
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœItaly
éµäŸ¿çªå·35017
é»è©±çªå·390499318173
ãŠã§ããµã€ãhttps://www.stevanatogroup.com/
äŒæ¥ã³ãŒãSTVN
äžå Žæ¥Jul 16, 2021
æé«çµå¶è²¬ä»»è
ãCEOãStevanato (Franco)